ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
39 announcements with these filters
CARE Ratings Q1 FY27 presentation highlights 18.9% consolidated revenue growth and 24.6% PAT growth. Expansion into global sovereign ratings and ESG services drives non-ratings momentum.
CARE Ratings has allotted 24,500 equity shares to employees following the exercise of options under its Employee Stock Option Scheme 2020.
CARE Ratings (CareEdge) reported strong Q1 FY27 results with consolidated operating income of Rs. 111.68 Cr, up 18.9% YoY, driven by growth in both Ratings and Non-Ratings segments.
CARE Ratings Limited reported its Q1 FY27 results, highlighting strong standalone revenue growth of 16.5% YoY and consolidated revenue growth of 18.9% YoY.
CARE Ratings Ltd reported revenue from operations of ₹111.7 Cr (+19.0% YoY) and net profit of ₹33 Cr (+24.5% YoY) for Q1 FY27.
CARE Ratings Limited allotted 6,766 equity shares to employees upon the exercise of stock options under its ESOP scheme.
CARE Ratings will hold a board meeting on August 7, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
CARE Ratings Ltd filed its shareholding pattern for the quarter ending June 30, 2026, detailing holdings across various investor categories. No monetary transactions were disclosed.
CARE Ratings allotted 26,733 shares to employees under its ESOP 2020. Paid-up capital rose to Rs.30.08 crore from Rs.30.06 crore.
CARE Ratings held its 33rd AGM, approving financials and declaring a final dividend of Rs.14 per share. All resolutions passed with requisite majority.
CARE Ratings Limited appointed Mr. Sanjay Agarwal as Chief Risk Officer effective August 1, 2026. The appointment adds seasoned risk expertise to the senior management team.
CARE Ratings delivered strong FY26 performance with consolidated revenue up 18% and PAT up 24%. Strategy focuses on scaling global rating entities and non-rating AI-driven analytics.
CARE Ratings delivered strong FY26 performance with 18% consolidated revenue growth and 24% PAT growth, driven by ratings and non-ratings segments.
CARE Ratings Limited allotted 11,250 equity shares under its ESOP scheme. The allotment increased the company's total paid-up share capital to ₹30.06 Crore.
CARE Ratings allotted 11,250 equity shares under its ESOP scheme. This increases paid-up capital and reflects employee stock option exercises.
CARE Ratings Limited has scheduled its Annual General Meeting for July 3, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
CARE Ratings Limited dispatched its FY 2025-26 Annual Report and 33rd AGM notice. The meeting is scheduled for July 3, 2026, via video conferencing.
Madras High Court vacated an asset alienation injunction against CARE Ratings after compliance. This resolution removes prior legal restraints on the company's asset operations.
CARE Ratings delivered strong Q4FY26 results with consolidated revenue growing 19% YoY to ₹130.67 Cr. Strategy focuses on AI adoption (60% staff usage) and expanding global sovereign and ESG rating services.
CARE Ratings delivered strong FY26 performance with consolidated revenue growth of 18% and PAT growth of 24%. Strategy focuses on scaling global ratings and AI-driven analytics.
CARE Ratings delivered strong FY26 performance with consolidated revenue growth of 18% and PAT growth of 24%. Strategy focuses on scaling global ratings and AI-embedded analytics.
CARE Ratings reported record financial performance in FY26, driven by a 16.1% surge in bank credit offtake and the successful turnaround of its non-ratings subsidiaries to profitability.
CARE Ratings delivered strong FY26 performance with consolidated revenue growing 18% to ₹473cr and PAT up 24% to ₹174cr. The company is pivoting towards AI-driven analytics and expanding its global rating footprint.
CARE Ratings recommended a final dividend of ₹14 per equity share. The record date is June 26, 2026, with payment scheduled by August 1, 2026.
CARE Ratings re-appointed B S R & Co. LLP as Statutory Auditors for five years. The decision ensures audit continuity following board approval.
CARE Ratings reported FY26 consolidated revenue of ₹473.07 Crore, up 18% year-on-year. The Board also recommended a final dividend of ₹14 per share.
CARE Ratings Ltd reported revenue from operations of ₹130.7 Cr (+19.1% YoY) and net profit of ₹53.4 Cr (+23.0% YoY) for Q4 FY26.
CARE Ratings approved FY26 audited financial results and recommended a ₹14 per share final dividend. It also approved a five-year statutory auditor re-appointment.
CARE Ratings Limited allotted 300 equity shares under its ESOP/ESPS scheme on May 4, 2026. This increased the company's paid-up share capital from ₹30,04,88,630 to ₹30,04,91,630.
CARE Ratings Limited allotted 300 equity shares pursuant to ESOP exercises and granted 18,000 new stock options at an exercise price of Rs. 1,590 per share (total value ₹2.86 Crore). The paid-up capital increased to ₹30.05 Crore. Options vest over three years and have a two-year exercise period thereafter.